AC Immune SAAC Immune SA - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The assessment of AC Immune SA leverages information from across the web and also from available documents by AC Immune SA. This SDG score for AC Immune SA indicates the company's reporting of the UN Sustainable Development Goals. This ESG rating includes 17 UN SDGs including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Partnerships for the Goals'.

AC Immune SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 1.6, social score of 6.4 and governance score of 8.0.

SDG Transparency Score for AC Immune SA 
Low
0 - 3

5.3

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for AC Immune SA 
1.6

Environmental

6.4

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
886Veracyte Inc
5.4
High
886Xlife Sciences AG
5.4
High
912AC Immune SA
5.3
High
912Acer Therapeutics Inc
5.3
High
912Alembic Pharmaceuticals Ltd
5.3
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does AC Immune SA have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does AC Immune SA disclose current and historical energy intensity?

LockedSign up for free to unlock

Does AC Immune SA report the average age of the workforce?

LockedSign up for free to unlock

Does AC Immune SA reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does AC Immune SA disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does AC Immune SA disclose cybersecurity risks?

LockedSign up for free to unlock

Does AC Immune SA offer flexible work?

LockedSign up for free to unlock

Does AC Immune SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does AC Immune SA disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does AC Immune SA conduct supply chain audits?

LockedSign up for free to unlock

Does AC Immune SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does AC Immune SA conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does AC Immune SA disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does AC Immune SA disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does AC Immune SA disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does AC Immune SA disclose water use targets?

LockedSign up for free to unlock

Does AC Immune SA have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did AC Immune SA have a product recall in the last two years?

LockedSign up for free to unlock

Does AC Immune SA disclose incidents of discrimination?

LockedSign up for free to unlock

Does AC Immune SA allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has AC Immune SA issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does AC Immune SA disclose parental leave metrics?

LockedSign up for free to unlock

Does AC Immune SA disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does AC Immune SA disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does AC Immune SA disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does AC Immune SA support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does AC Immune SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does AC Immune SA reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is AC Immune SA involved in embryonic stem cell research?

LockedSign up for free to unlock

Does AC Immune SA disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does AC Immune SA disclose its waste policy?

LockedSign up for free to unlock

Does AC Immune SA report according to TCFD requirements?

LockedSign up for free to unlock

Does AC Immune SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does AC Immune SA disclose energy use targets?

LockedSign up for free to unlock

Does AC Immune SA disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does AC Immune SA have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for AC Immune SA
These potential risks are based on the size, segment and geographies of the company.

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD). It is also developing ACI-24, an anti-Abeta vaccine candidate that is in Phase II clinical study for AD, as well as completed Phase Ib clinical study for Down syndrome; ACI-35, an anti-Tau vaccine candidate that has completed Phase Ib clinical study; and Tau- positron emission tomography (PET) imaging tracer, which is in Phase II clinical study. In addition, the company is researching and developing small molecule Tau aggregation inhibitors for AD and NeuroOrphan indications. Further, it has discovery and preclinical stage molecules targeting range of neurodegenerative diseases, which include diagnostics targeting TDP-43, alpha-synuclein, and NLRP3. The company has license agreements and collaborations with Genentech, Inc.; Biogen International GmbH; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; Eli Lilly and Company; and WuXi Biologics. AC Immune SA was incorporated in 2003 and is headquartered in Lausanne, Switzerland.

Sorry!

Failed to process!